|
HS Code |
372756 |
As an accredited 7-Bromo-2-Methylindazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 7-Bromo-2-Methylindazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
People in research labs often look for building blocks that open doors to new experiments. 7-Bromo-2-methylindazole isn’t some background chemical on a shelf – it stands out because of the way it shapes synthesis strategies. Its unique structure allows for chemistry that’s hard to achieve with others in the family of indazoles. I remember sitting with a group of medicinal chemists while they puzzled over selective bromination, and this compound brought some real excitement into the conversation.
With a molecular formula of C8H7BrN2 and a solid crystalline appearance, it offers much more than its simple description. The methyl group at the 2-position and the bromo at the 7-position make all the difference. Unlike similar indazoles that lack such substitution, this one brings both reactivity and selectivity. The spot on the indazole ring where bromine is attached lets researchers introduce further changes, whether that’s swapping out the bromine or building a more complex molecule step by step.
Beyond the basics of melting point and purity, this compound’s defining characteristic lies in the way its positions are substituted. The methyl group on the second carbon doesn’t just change physical properties, it impacts electron density across the molecule. That means it interacts differently under standard laboratory conditions, something researchers testing for activity in pharmaceutical intermediates care about. The bromine sitting at carbon seven gives scientists a chemical “handle,” making it easier to attach more diverse groups through typical cross-coupling reactions, such as Suzuki or Buchwald-Hartwig amination. These reactions are workhorses in creating new medicine candidates.
In my own projects, I’ve seen how swapping a bromine between ring carbons can be the difference between a reaction pathway that stops cold and one that actually reaches a finished material. With 7-bromo-2-methylindazole, the bromination isn’t random – it usually comes from carefully controlling reaction conditions and using the right catalyst. Most suppliers today standardize around high-purity forms with melting points close to the expected 150-154°C range. A sharp, consistent melting point is critical for reproducibility and for confirming identity before any scale-up.
A chemist often debates which indazole fits their experimental goal. Take 2-methylindazole without the bromine; this compound serves as a decent building block for some synthesis steps, but lacks that reactive point of attachment the halogen offers. When you’re building a library of compounds – for a drug discovery program, for example – you want something that lets you add new side chains with reliable chemistry. The presence of the bromo group means you can use standard protocols, saving both time and money.
I’ve watched as colleagues pulled their hair out over regioselectivity, especially when trying to selectively add groups to certain positions around the indazole core. With 7-bromo-2-methylindazole, you sidestep much of that frustration – the regioselectivity has already been baked in. Compare that to other halogenated indazoles, and you see a real advantage here. For instance, 4-bromo or 5-bromo versions might be useful for other applications, but they can behave unpredictably in cross-coupling reactions, leading to a tangle of side products. The 7-position tends to strike a better balance, making purification smoother and improving the overall efficiency of the workflow.
On the physical chemistry side, solubility takes a jump forward because the methyl group offers just enough lipophilicity for organic solvents, but doesn’t sacrifice solid-handling convenience. Every scale-up chemist learns to love a compound that resists clumping or excessive hygroscopicity during weighing and storage. Purity analysis using NMR and HPLC lines up cleanly, another reason larger synthesis teams keep this molecule on hand for quick deployment.
The buzz around 7-bromo-2-methylindazole isn’t only among bench chemists. Over the last decade, more drug discovery teams have adapted strategies that rely on it for making biologically active compounds. The pharmaceutical industry benefits from its ready compatibility with palladium-catalyzed reactions, which are now staple tools for building small molecule therapies. In targeting kinases, proteases, or other key enzymes, having a precise indazole core with controlled substitution improves selectivity and reduces off-target effects. In practice, a project manager overseeing early-stage drug discovery prefers building blocks with a well-defined synthesis history and clean safety profiles, both of which are established for this compound.
Another application emerges in materials chemistry. Scientists exploring electronic and photonic properties of organic materials need scaffold molecules with predictable reactivity and strong aromaticity. By tweaking the indazole nucleus, particularly with the methyl and bromine pair, they shape the resulting molecular packing and thus the performance in devices such as sensors or OLED displays.
On both fronts – pharma and materials – one of the big selling points remains how this compound threads the needle between versatility and manageability. A research group racing to optimize a lead compound values that the reactivity profile is supported by ample literature, meaning operational blind spots are rare. For younger scientists or those at smaller startups, that’s a difference-maker.
I’ve spent hours in labs prepping batches of substituted indazoles, and nothing annoys you faster than inconsistent handling or impure starting materials. 7-bromo-2-methylindazole ships as a stable, easily weighed crystalline powder. Lab teams appreciate how little it tends to absorb moisture, especially during humid months when open vials are a recipe for mess.
As a teacher and team lead, I’ve introduced graduate students to this compound for entry-level cross-coupling. The reactions set up reliably, with high yields most of the time. Students appreciate that even minor deviations from protocol rarely derail the process. Loader and transfer steps work smoothly with conventional lab tools, and fluorescence under UV light provides a quick read on purity for those who know what to look for.
Shipping, storage, and documentation rarely become headaches because 7-bromo-2-methylindazole meets transportation guidelines for laboratory chemicals. Most suppliers run thorough assessments on batch consistency, and the chain-of-custody paperwork satisfies institutional purchasing departments. In a regulated environment, that level of confidence moves things forward quickly.
The jump from a “plain” indazole to the 7-bromo-2-methyl version seems straightforward on paper, but real-world performance tells the story. Some researchers stick with unsubstituted indazoles and try to force the chemistry to work for their needs. That usually leads to longer reaction times, unnecessary byproducts, and painful purification. In my experience, the extra up-front cost is offset by shorter timelines downstream when using the 7-bromo variant.
The main difference compared to other halogenated indazoles often comes down to both the position of the halogen and the electron-donating effects of the methyl. That pairing changes chemical reactivity in ways that show up in key reactions. Take something like Suzuki coupling: the 7-bromo site reacts more cleanly, and the methyl group stabilizes intermediates that might otherwise decompose.
For scale-up teams assessing new routes, picking this version helps smooth regulatory scrutiny, since its impurity profiles are well documented in the published literature. Some similar compounds, especially those substituted elsewhere on the ring, don’t have such a consistent track record. That can gum up approval processes and delay project milestones.
Demand for specialized building blocks like 7-bromo-2-methylindazole has climbed, especially with the surge in biotech and materials innovation. As more projects push for unique molecular architectures, supply chain management becomes crucial. Smaller labs sometimes face high prices or batch shortages. In my view, addressing these gaps starts with stronger collaborations between academic groups and reliable suppliers, who can forecast demand better thanks to open communication.
Quality control remains a cornerstone of trust for any research-based purchase. Labs can partner with providers that back up purity claims with third-party analysis data. Peer review processes, open publication of synthetic routes, and transparency around analytical data shore up confidence for the end-user. Regular participation in proficiency testing can also keep standards high, turning what often feels like a black box into a pillar of process reproducibility.
Another hot topic concerns green chemistry approaches. Manufacturing specialty molecules without generating tons of hazardous waste grows more important each year. Some suppliers have begun adopting catalytic processes, reducing the reliance on harsh solvents and metals. Encouraging more widespread adoption of cleaner bromination methodologies will help keep the environmental impact reasonable as volumes increase.
Drug discovery races against the clock, and the smartest teams I know spend less time re-inventing starting material procurement and more time designing new transformations. Using off-the-shelf compounds like 7-bromo-2-methylindazole, with well-charted reaction profiles, limits surprises in high-throughput screening campaigns. For those working at the bench daily, the convenience of using a reliable substrate takes stress out of planning – you get more predictable timelines, fewer failed runs, and higher morale on both small and large teams.
As regulations and expectations rise for documentation, especially in pharma, compounds with well-established properties and literature references keep compliance overhead low. Colleagues working at regulatory edges often mention that their project timelines stay on track partly thanks to less back-and-forth with supply chain and documentation support. Every scientist dreams of a world where bench chemistry isn’t constantly derailed by procurement or quality hiccups; using robust, established materials like this one brings that world closer.
The potential of 7-bromo-2-methylindazole doesn’t hit a ceiling at drug development. Growing numbers of materials scientists who are trying to tune optoelectronic properties find the indazole nucleus a flexible tool. Changing position and type of substitution pushes absorption and emission wavelengths, or changes the stacking in thin films. The 7-bromo-2-methyl template sits at an intersection where it enables new trials without requiring wild, untested chemistry.
Academics exploring fundamental reactivity routinely publish innovative ligand development pathways or sensor prototypes using modified indazoles. As synthetic challenges grow tougher, and the need for cross-discipline innovation spikes, having a starting point that offers both chemical resilience and tractable downstream modifications becomes a quiet advantage. I once watched a polymer chemistry team tackle a barrier layer for organic circuits by tweaking the substituents on just this type of indazole; the right combination opened a door that previous attempts couldn’t.
Opportunities also exist in the agrochemical and dye industries. The predictable behavior of this scaffold under sulfonation, chlorination, and diazotization opens up options for those looking to incorporate it into pigments or other specialty compounds.
The culture among scientists handling 7-bromo-2-methylindazole supports open discussion and shared troubleshooting. Online boards, preprint servers, and peer-reviewed journals all provide case studies and improvements to synthetic techniques involving this molecule. I’ve sat through many group meetings where a single tweak picked up from the literature made a week’s work possible. In my experience, these conversations keep mistakes from repeating and allow teams to iterate quickly – something that’s difficult with less-documented building blocks.
Mentorship also plays a role. Experienced chemists who’ve handled scale-ups or particularly challenging syntheses often pass along insights about temperature controls, solvent choices, or storage tricks to colleagues new to the molecule. This culture of mentorship keeps avoidable pitfalls rare, while encouraging the sort of risk-taking that leads to real discoveries.
Professional societies and supplier webinars have started drilling into the nuts and bolts of using these building blocks in specialized synthesis. These resources, free or low-cost, cover everything from laboratory hazard management to reaction optimization in the context of modern green chemistry. Skilled scientists now build on what’s known, rather than relearning lessons that others have already worked out.
Looking across all sectors – pharmaceutical, materials, and beyond – it’s clear that 7-bromo-2-methylindazole fills a distinctive spot in today’s chemical toolkit. From its carefully engineered structure, which brings both reactivity and manageability, to a growing body of literature that supports its safety and utility, researchers benefit every time they reach for this compound. As science shifts toward faster innovation cycles and tighter environmental standards, the demand for such reliable, well-understood building blocks will only grow. I see the continuing adoption of this molecule as a model for how the scientific community can merge creativity with practicality, paving the way for more streamlined discoveries in years to come.